SOLVAY SA (SOLB.BR) Stock Fundamental Analysis

EBR:SOLB • BE0003470755

27.1 EUR
0 (0%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SOLB. SOLB was compared to 66 industry peers in the Chemicals industry. SOLB has a medium profitability rating, but doesn't score so well on its financial health evaluation. SOLB is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SOLB was profitable.
  • In the past year SOLB had a positive cash flow from operations.
  • Of the past 5 years SOLB 4 years were profitable.
  • In the past 5 years SOLB always reported a positive cash flow from operatings.
SOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

  • SOLB has a Return On Assets (2.43%) which is comparable to the rest of the industry.
  • SOLB's Return On Equity of 12.80% is fine compared to the rest of the industry. SOLB outperforms 71.21% of its industry peers.
  • SOLB's Return On Invested Capital of 8.40% is fine compared to the rest of the industry. SOLB outperforms 74.24% of its industry peers.
  • SOLB had an Average Return On Invested Capital over the past 3 years of 11.19%. This is above the industry average of 7.06%.
Industry RankSector Rank
ROA 2.43%
ROE 12.8%
ROIC 8.4%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
SOLB.BR Yearly ROA, ROE, ROICSOLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • SOLB has a Profit Margin (3.14%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of SOLB has grown nicely.
  • The Operating Margin of SOLB (10.89%) is better than 71.21% of its industry peers.
  • SOLB's Operating Margin has improved in the last couple of years.
  • SOLB has a worse Gross Margin (21.24%) than 66.67% of its industry peers.
  • SOLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.89%
PM (TTM) 3.14%
GM 21.24%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
SOLB.BR Yearly Profit, Operating, Gross MarginsSOLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SOLB is creating value.
  • The number of shares outstanding for SOLB has been reduced compared to 1 year ago.
  • The number of shares outstanding for SOLB has been increased compared to 5 years ago.
  • The debt/assets ratio for SOLB is higher compared to a year ago.
SOLB.BR Yearly Shares OutstandingSOLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SOLB.BR Yearly Total Debt VS Total AssetsSOLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • SOLB has an Altman-Z score of 1.69. This is a bad value and indicates that SOLB is not financially healthy and even has some risk of bankruptcy.
  • SOLB has a Altman-Z score of 1.69. This is in the lower half of the industry: SOLB underperforms 71.21% of its industry peers.
  • SOLB has a debt to FCF ratio of 7.54. This is a slightly negative value and a sign of low solvency as SOLB would need 7.54 years to pay back of all of its debts.
  • SOLB has a better Debt to FCF ratio (7.54) than 60.61% of its industry peers.
  • A Debt/Equity ratio of 1.70 is on the high side and indicates that SOLB has dependencies on debt financing.
  • The Debt to Equity ratio of SOLB (1.70) is worse than 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 7.54
Altman-Z 1.69
ROIC/WACC1.36
WACC6.18%
SOLB.BR Yearly LT Debt VS Equity VS FCFSOLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • SOLB has a Current Ratio of 1.41. This is a normal value and indicates that SOLB is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SOLB (1.41) is worse than 68.18% of its industry peers.
  • A Quick Ratio of 1.04 indicates that SOLB should not have too much problems paying its short term obligations.
  • SOLB has a Quick ratio (1.04) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.04
SOLB.BR Yearly Current Assets VS Current LiabilitesSOLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

  • SOLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.13%.
  • Measured over the past years, SOLB shows a very strong growth in Earnings Per Share. The EPS has been growing by 153.72% on average per year.
  • Looking at the last year, SOLB shows a very negative growth in Revenue. The Revenue has decreased by -50.46% in the last year.
  • The Revenue for SOLB have been decreasing by -14.50% on average. This is quite bad
EPS 1Y (TTM)-93.13%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-16.16%
Revenue 1Y (TTM)-50.46%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-9.69%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.99% on average over the next years.
  • SOLB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.40% yearly.
EPS Next Y-20.44%
EPS Next 2Y-15.18%
EPS Next 3Y-5.88%
EPS Next 5Y-2.99%
Revenue Next Year-4.56%
Revenue Next 2Y-2.21%
Revenue Next 3Y-0.48%
Revenue Next 5Y-0.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLB.BR Yearly Revenue VS EstimatesSOLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
SOLB.BR Yearly EPS VS EstimatesSOLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.42, the valuation of SOLB can be described as very cheap.
  • 96.97% of the companies in the same industry are more expensive than SOLB, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of SOLB to the average of the S&P500 Index (26.99), we can say SOLB is valued rather cheaply.
  • SOLB is valuated reasonably with a Price/Forward Earnings ratio of 9.21.
  • SOLB's Price/Forward Earnings ratio is rather cheap when compared to the industry. SOLB is cheaper than 98.48% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, SOLB is valued rather cheaply.
Industry RankSector Rank
PE 7.42
Fwd PE 9.21
SOLB.BR Price Earnings VS Forward Price EarningsSOLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SOLB is valued cheaper than 90.91% of the companies in the same industry.
  • 96.97% of the companies in the same industry are more expensive than SOLB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.79
EV/EBITDA 5.66
SOLB.BR Per share dataSOLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of SOLB may justify a higher PE ratio.
  • SOLB's earnings are expected to decrease with -5.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-15.18%
EPS Next 3Y-5.88%

5

5. Dividend

5.1 Amount

  • SOLB has a Yearly Dividend Yield of 5.97%, which is a nice return.
  • SOLB's Dividend Yield is rather good when compared to the industry average which is at 2.11. SOLB pays more dividend than 95.45% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SOLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.97%

5.2 History

  • The dividend of SOLB decreases each year by -9.94%.
Dividend Growth(5Y)-9.94%
Div Incr Years3
Div Non Decr Years4
SOLB.BR Yearly Dividends per shareSOLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • SOLB pays out 164.94% of its income as dividend. This is not a sustainable payout ratio.
  • SOLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP164.94%
EPS Next 2Y-15.18%
EPS Next 3Y-5.88%
SOLB.BR Yearly Income VS Free CF VS DividendSOLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
SOLB.BR Dividend Payout.SOLB.BR Dividend Payout, showing the Payout Ratio.SOLB.BR Dividend Payout.PayoutRetained Earnings

SOLVAY SA

EBR:SOLB (2/20/2026, 7:00:00 PM)

27.1

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)02-24
Inst Owners29.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.87B
Revenue(TTM)4.91B
Net Income(TTM)154.00M
Analysts52.8
Price Target26.93 (-0.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.97%
Yearly Dividend2.44
Dividend Growth(5Y)-9.94%
DP164.94%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.12%
Min EPS beat(2)9%
Max EPS beat(2)31.25%
EPS beat(4)3
Avg EPS beat(4)12.33%
Min EPS beat(4)-1.96%
Max EPS beat(4)31.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.19%
Min Revenue beat(4)-4.75%
Max Revenue beat(4)-0.57%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)5
Avg Revenue beat(12)2.07%
Revenue beat(16)9
Avg Revenue beat(16)7.99%
PT rev (1m)-4.58%
PT rev (3m)-9.9%
EPS NQ rev (1m)-21.74%
EPS NQ rev (3m)-31.82%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)-0.12%
Revenue NQ rev (1m)-1.97%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 7.42
Fwd PE 9.21
P/S 0.58
P/FCF 9.79
P/OCF 4.81
P/B 2.39
P/tB 12.7
EV/EBITDA 5.66
EPS(TTM)3.65
EY13.47%
EPS(NY)2.94
Fwd EY10.85%
FCF(TTM)2.77
FCFY10.21%
OCF(TTM)5.63
OCFY20.77%
SpS46.33
BVpS11.36
TBVpS2.13
PEG (NY)N/A
PEG (5Y)0.05
Graham Number30.55
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 12.8%
ROCE 11.2%
ROIC 8.4%
ROICexc 8.4%
ROICexgc 10.56%
OM 10.89%
PM (TTM) 3.14%
GM 21.24%
FCFM 5.97%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
ROICexc(3y)12.43%
ROICexc(5y)9.87%
ROICexgc(3y)17.2%
ROICexgc(5y)14.4%
ROCE(3y)14.91%
ROCE(5y)11.94%
ROICexgc growth 3Y8.77%
ROICexgc growth 5Y9.63%
ROICexc growth 3Y18.23%
ROICexc growth 5Y16.44%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 7.54
Debt/EBITDA 2.28
Cap/Depr 83.47%
Cap/Sales 6.18%
Interest Coverage 7.63
Cash Conversion 66.44%
Profit Quality 190.26%
Current Ratio 1.41
Quick Ratio 1.04
Altman-Z 1.69
F-Score5
WACC6.18%
ROIC/WACC1.36
Cap/Depr(3y)94.75%
Cap/Depr(5y)76.26%
Cap/Sales(3y)9.62%
Cap/Sales(5y)7.99%
Profit Quality(3y)83.5%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.13%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-16.16%
EPS Next Y-20.44%
EPS Next 2Y-15.18%
EPS Next 3Y-5.88%
EPS Next 5Y-2.99%
Revenue 1Y (TTM)-50.46%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-9.69%
Revenue Next Year-4.56%
Revenue Next 2Y-2.21%
Revenue Next 3Y-0.48%
Revenue Next 5Y-0.4%
EBIT growth 1Y-59.02%
EBIT growth 3Y-19.61%
EBIT growth 5Y-11.06%
EBIT Next Year21.58%
EBIT Next 3Y9.38%
EBIT Next 5Y5.74%
FCF growth 1Y-75.88%
FCF growth 3Y-27.42%
FCF growth 5Y-19.2%
OCF growth 1Y-74.87%
OCF growth 3Y-25.69%
OCF growth 5Y-19.46%

SOLVAY SA / SOLB.BR FAQ

What is the ChartMill fundamental rating of SOLVAY SA (SOLB.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SOLB.BR.


What is the valuation status of SOLVAY SA (SOLB.BR) stock?

ChartMill assigns a valuation rating of 8 / 10 to SOLVAY SA (SOLB.BR). This can be considered as Undervalued.


What is the profitability of SOLB stock?

SOLVAY SA (SOLB.BR) has a profitability rating of 6 / 10.


What is the valuation of SOLVAY SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SOLVAY SA (SOLB.BR) is 7.42 and the Price/Book (PB) ratio is 2.39.


Can you provide the financial health for SOLB stock?

The financial health rating of SOLVAY SA (SOLB.BR) is 3 / 10.